4.7 Article

A novel numerical and artificial intelligence based approach to study anti-angiogenic drugs: Endostatin

Journal

APPLIED MATHEMATICAL MODELLING
Volume 105, Issue -, Pages 258-283

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.apm.2021.12.033

Keywords

Anti-angiogenesis; Endostatin; Neural network; Mathematical oncology

Ask authors/readers for more resources

Angiogenesis plays a crucial role in vascular tumor growth. Anti-angiogenesis is used to suppress tumor growth and improve drug delivery. Combined therapies with chemotherapy and radiotherapy can achieve better outcomes in cancer treatment.
Angiogenesis is known as the key factor in vascular tumor growth. In addition to fur-nishing the tumor with fresh nutrients to survive and spread to the other tissues, tumor-induced vasculature is tortuous and contains leaky vessels. Therefore, anti-angiogenesis is introduced as a way to suppress tumor growth and preclude metastases. Secondly, method of normalization of tortuous tumor-induced vasculature is being used to ease drug deliv-ery to the tumor site. And thirdly, combined therapies of chemotherapy and radiotherapy with anti-angiogenesis agents can help achieve better outcomes in cancer treatment. One endogenous anti-angiogenesis agent that is being used in the aforementioned treatment strategies is known to be endostatin. In this research, a novel formulation is proposed and a computer code is developed to study anti-angiogenesis effects of endostatin. It is shown that endostatin as an endogenous agent can suppress angiogenesis and normalize tumor-induced vasculature which can ease drug delivery to the tumor site. By increasing endo-statin concentration to 5 times of its natural concentration in the blood plasma of cancer patients, angiogenesis could be tackled and hindered. Finally, in order to propose a general and simple formulation to predict final microvessel density at different circumstances, a Generalized Regression Neural Network (GRNN) is established. The results of GRNN show that it is able to predict the microvascular density with 87% accuracy. With the aim of GRNN formulation, scientists can observe the vasculature at any desired conditions to get an insight on optimum time for the combined treatment.(c) 2022 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available